CRISPR-Based Detection Platform
The CRISPR-based detection platform: Our revolutionary method for molecular diagnostics, enabling limitless testing possibilities.
- Single Nucleotide Polymorphisms (SNP)
- Bacterial Infections
- Cancer Screening and Profiling
- Antimicrobial Resistance
- Viral Infections
DETECTR searches for the presence of specific nucleic acids in a sample that are indicative of disease, providing actionable clinical information.
Our proprietary testing system works by employing CRISPR nucleases, programmed to find a defined gene sequence. Upon finding the sequence of interest, the nuclease activates a cleavage capability, which generates a signal. The signal confirms the sequence has been found.
Simple
Molecular-based diagnosis
Our CRISPR-powered diagnostics provide unambiguous results in an instrument-free and disposable format.
Fast
Results within 20 minutes
Signal amplification by CRISPR accelerates target detection and is compatible with multiple sample matrices.
Programmable
Construct a test for any target
DETECTR can be quickly tailored to identify any DNA or RNA target using our CRISPR nuclease toolbox and gRNA design pipeline.